How big is the single-photon emission computed tomography market?

The market revenue for single-photon emission computed tomography is anticipated at USD 4.13 billion in 2027.

What is the expected industry size of single-photon emission computed tomography by 2036?

Single-Photon Emission Computed Tomography Market size was valued at USD 4.04 billion in 2026 and is anticipated to grow at a 2.64% CAGR from 2027 to 2036, crossing USD 5.24 billion by 2036.

How is oncology demand influencing investment in SPECT imaging systems?

Increasing need for functional disease assessment is encouraging healthcare providers to upgrade nuclear imaging capabilities, supporting demand for SPECT systems with stronger clinical utility and workflow integration.

Why are hybrid SPECT/CT systems gaining importance in diagnostic imaging modernization?

Healthcare institutions are favoring integrated SPECT/CT platforms because they combine anatomical and functional imaging, improving diagnostic precision and supporting more efficient patient management workflows.

Why is oncology the leading application in the single-photon emission computed tomography (SPECT) market?

Oncology accounted for 49.98% of the market in 2026 and remains the fastest-growing application because SPECT is widely used to assess cancer progression, treatment response, and ongoing patient management.

Why are diagnostics imaging centers the fastest-growing end-use segment in the single-photon emission computed tomography (SPECT) market?

Diagnostics imaging centers are expanding fastest as providers and patients increasingly value dedicated outpatient imaging services that offer streamlined scheduling, efficient workflows, and improved access for routine SPECT procedures.

Why is North America the largest SPECT market?

North America leads with 46.56% share due to strong nuclear imaging infrastructure, widespread clinical use in cardiology and oncology, and established hospital-based diagnostic workflows.

How is Asia Pacific contributing to growth in the SPECT market?

Asia Pacific is growing at 3.31% CAGR as healthcare systems expand imaging access, invest in diagnostic capacity, and gradually integrate advanced nuclear medicine technologies into clinical practice.

Who are the major participants shaping the single-photon emission computed tomography landscape?

Prominent players in the single-photon emission computed tomography market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Spectrum Dynamics Medical Ltd. (Israel), Mediso Medical Imaging Systems Ltd. (Hungary), MiE GmbH (Germany), Canon Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), TTG Imaging Solutions, LLC (Digirad Corporation) (United States), Rigaku Corporation (MILabs B.V.) (Japan).